Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis
- PMID: 31832574
- PMCID: PMC6887930
- DOI: 10.1002/hep4.1433
Up-regulation of miR-let7a-5p Leads to Decreased Expression of ABCC2 in Obstructive Cholestasis
Abstract
Adenosine triphosphate-binding cassette subfamily C member 2 (ABCC2/Abcc2) is critically important to biliary excretion of many endobiotic and xenobiotic compounds, and is a major driving force for bile acid-independent bile flow. Abcc2 expression is reduced at the messenger RNA (mRNA) and protein levels in various forms of experimental cholestasis. In a microRNA (miRNA) screen of mouse liver after biliary obstruction, we found that miRNA let7a-5p was significantly up-regulated approximately 4-fold. Similarly, ABCC2 mRNA was depleted and miRNA let7a-5p was elevated over 4-fold in livers of children with biliary atresia compared with normal livers. In silico analysis predicted that let7a-5p would target the 3' untranslated region (3' UTR) of ABCC2/Abcc2 RNA. The objective of this study was to determine whether let7a-5p contributes to the depletion of ABCC2/Abcc2 in cholestasis. To demonstrate the functional importance of miRNA let7a-5p in regulating the expression of ABCC2, co-transfection of a let7a-5p mimic and an ABCC2-3' UTR luciferase construct into Huh-7 cells led to a marked inhibition of luciferase activity by about 60%-70% compared with controls, which was reversed by a let7a-5p mimic inhibitor. Expression of this mimic led to a significant decrease in endogenous ABCC2 mRNA and protein levels in a Huh-7 liver cell line, which could be blocked by expression of a let7a-5p mimic inhibitor. Injection of a lentivirus let7a-5p inhibitor into normal mouse liver or into mouse liver after common bile duct ligation led to a significant increase in endogenous Abcc2 mRNA and protein levels and a depletion of let7a-5p mRNA levels compared with untreated, saline-injected livers or livers treated with an inactive lentivirus control. Conclusion: These studies demonstrate that miR-let7a-5p is involved in regulating ABCC2/Abcc2 expression, and is aberrantly up-regulated in obstructive cholestasis.
© 2019 The Authors. Hepatology Communications published by Wiley Periodicals, Inc., on behalf of the American Association for the Study of Liver Diseases.
Figures










Similar articles
-
miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis.J Biol Chem. 2021 Dec;297(6):101400. doi: 10.1016/j.jbc.2021.101400. Epub 2021 Nov 12. J Biol Chem. 2021. PMID: 34774795 Free PMC article.
-
Elevated hepatic MDR3/ABCB4 is directly mediated by MiR-378a-5p in human obstructive cholestasis.Eur Rev Med Pharmacol Sci. 2019 Mar;23(6):2539-2547. doi: 10.26355/eurrev_201903_17402. Eur Rev Med Pharmacol Sci. 2019. PMID: 30964181
-
Down-regulation of ATP-binding cassette C2 protein expression in HepG2 cells after rifampicin treatment is mediated by microRNA-379.Mol Pharmacol. 2011 Aug;80(2):314-20. doi: 10.1124/mol.110.070714. Epub 2011 May 3. Mol Pharmacol. 2011. PMID: 21540293
-
LncRNA SNHG5 regulates imatinib resistance in chronic myeloid leukemia via acting as a CeRNA against MiR-205-5p.Am J Cancer Res. 2017 Aug 1;7(8):1704-1713. eCollection 2017. Am J Cancer Res. 2017. PMID: 28861326 Free PMC article.
-
miR-146a-5p Regulated Cell Proliferation and Apoptosis by Targeting SMAD3 and SMAD4.Protein Pept Lett. 2020;27(5):411-418. doi: 10.2174/0929866526666190911142926. Protein Pept Lett. 2020. PMID: 31544687 Free PMC article.
Cited by
-
The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease.PLoS One. 2022 Nov 15;17(11):e0276879. doi: 10.1371/journal.pone.0276879. eCollection 2022. PLoS One. 2022. PMID: 36378690 Free PMC article.
-
MicroRNAs in chronic pediatric diseases (Review).Exp Ther Med. 2024 Jan 15;27(3):100. doi: 10.3892/etm.2024.12388. eCollection 2024 Mar. Exp Ther Med. 2024. PMID: 38356668 Free PMC article. Review.
-
Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model.World J Gastroenterol. 2024 Feb 7;30(5):471-484. doi: 10.3748/wjg.v30.i5.471. World J Gastroenterol. 2024. PMID: 38414587 Free PMC article.
-
Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins.Heliyon. 2025 Jan 2;11(1):e41629. doi: 10.1016/j.heliyon.2025.e41629. eCollection 2025 Jan 15. Heliyon. 2025. PMID: 39866414 Free PMC article. Review.
-
Increased ABCC2 expression predicts cisplatin resistance in non-small cell lung cancer.Cell Biochem Funct. 2021 Mar;39(2):277-286. doi: 10.1002/cbf.3577. Epub 2020 Aug 20. Cell Biochem Funct. 2021. PMID: 32815556 Free PMC article.
References
-
- Keppler D. Progress in the molecular characterization of hepatobiliary transporters. Dig Dis 2017;35:197‐202. - PubMed
-
- Keppler D, Konig J. Hepatic canalicular membrane 5: expression and localization of the conjugate export pump encoded by the MRP2 (cMRP/cMOAT) gene in liver. FASEB J 1997;11:509‐516. - PubMed
-
- Keppler D, Konig J, Buchler M. The canalicular multidrug resistance protein, cMRP/MRP2, a novel conjugate export pump expressed in the apical membrane of hepatocytes. Adv Enzyme Regul 1997;37:321‐333. - PubMed
-
- Trauner M, Arrese M, Soroka CJ, Ananthanarayanan M, Koeppel TA, Schlosser SF, et al. The rat canalicular conjugate export pump (Mrp2) is down‐regulated in intrahepatic and obstructive cholestasis. Gastroenterology 1997;113:255‐264. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources